Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Adler-Moore

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Microbiology (Reading, England)|March 24, 2007
In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetryKasturi Mukhopadhyay, William Whitmire, Yan Q Xiong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2019
Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese IndividualsRoeland E Wasmann, Cornelis Smit, Eric P H van Dongen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Liposomal amphotericin B for the treatment of visceral leishmaniasisCaryn Bern, Jill Adler-Moore, Juan Berenguer, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Microbiology (Reading, England)|March 24, 2007
In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetryKasturi Mukhopadhyay, William Whitmire, Yan Q Xiong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2019
Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese IndividualsRoeland E Wasmann, Cornelis Smit, Eric P H van Dongen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Liposomal amphotericin B for the treatment of visceral leishmaniasisCaryn Bern, Jill Adler-Moore, Juan Berenguer, et al.
Pageof 2